Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases.

TitleAlloimmunization after blood transfusion in patients with hematologic and oncologic diseases.
Publication TypeJournal Article
Year of Publication1999
AuthorsSchonewille H, Haak HL, van Zijl AM
JournalTransfusion
Volume39
Issue7
Pagination763-71
Date Published1999 Jul
Abstract

Because of intensive marrow depression and improved survival, patients with hematologic and oncologic malignancies are dependent on transfusion for a longer period. It has been advocated that these patients should receive blood that is matched for blood group antigens other than ABO and D. A retrospective study was performed on the rate of alloimmunization against red cell antigens in 564 patients with malignant hematologic diseases over a period of 10 years.

Alternate JournalTransfusion